CareDx, Inc. CDNA
63.68
2.31
3.76%
as of 25 Sep
- Market cap
- $3.2B
- P/E
- 29.6×
Follow CDNA
Growth Flags
show if company had growth for consecutive years
| Older periods | Sep '25 | Dec '25 | Mar '26 | Jun '26 | |
|---|---|---|---|---|---|
P/E ratio |
+8 more quarters Free account |
11.18 | 0.00 | 0.00 | 13.26 |
P/S ratio |
2.13 | 2.64 | 2.15 | 3.20 | |
P/FCF ratio |
21.49 | 29.06 | 14.03 | 17.64 | |
P/Operating CF |
20.44 | 46.99 | 204.94 | 47.93 | |
P/B ratio |
2.45 | 3.31 | 2.83 | 3.45 | |
Price to Tangible BV |
3.22 | 4.35 | 3.68 | 3.95 | |
EV/Sales |
1.69 | 2.27 | 1.78 | 2.46 | |
EV/EBITDA |
7.31 | 0.00 | 124.06 | 8.68 | |
EV/Operating CF |
14.20 | 20.51 | 10.09 | 12.05 | |
EV/FCF |
17.02 | 24.95 | 11.63 | 13.57 | |
Quick Ratio |
2.44 | 2.45 | 2.93 | 4.35 | |
Current Ratio |
3.03 | 2.86 | 3.40 | 4.58 | |
Net Debt/EBITDA |
(23.96) | 54.39 | (25.20) | (3.17) | |
Debt/Assets |
0.00% | 0.00% | 0.00% | 0.00% | |
Debt/Equity |
0.00 | 0.00 | 0.00 | 0.00 | |
Asset Turnover |
0.79 | 0.84 | 0.92 | 0.94 | |
Operating CF/Net income |
22.30 | (5.20) | 1.54 | 0.28 | |
Capex/Depreciation |
(0.24) | (0.71) | (0.61) | (0.41) | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
16.76% | 17.81% | 18.20% | 16.96% | |
Selling, General and Administrative Expense of Revenue |
52.85% | 55.00% | 51.71% | 56.35% | |
Intangible Assets out of Total Assets |
0.17 | 0.18 | 0.18 | 0.10 | |
Share Based Compensation of Revenue |
8.41% | 7.46% | 8.33% | 8.07% | |
Graham Net Nets |
0.23 | 0.15 | 0.19 | 0.22 | |
Graham Number |
13.17 | 0.00 | 0.00 | 20.00 | |
Earnings Yield |
8.94% | (2.12%) | (0.92%) | 7.54% | |
Free Cash Flow Yield |
4.65% | 3.44% | 7.13% | 5.67% | |
Revenue per Share |
1.91 | 2.03 | 2.30 | 2.56 | |
Operating CF per Share |
0.71 | 0.40 | 0.08 | 0.59 | |
Capex per Share |
(0.04) | (0.04) | (0.07) | (0.04) | |
Free Cash Flow per Share |
0.67 | 0.36 | 0.01 | 0.56 | |
Cash per Share |
3.70 | 3.33 | 3.66 | 7.26 | |
Shareholders Equity per Share |
5.93 | 5.69 | 6.13 | 8.27 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
5.93 | 5.69 | 6.13 | 8.27 | |
Free Cash Flow |
35.38 | 19.39 | 0.51 | 28.75 | |
Working Capital |
201.24 | 167.28 | 190.24 | 335.53 | |
Capital Expenditures |
(1.98) | (1.97) | (3.82) | (1.86) | |
Net Current Asset Value |
179.11 | 147.01 | 171.87 | 321.83 | |
EV/EBIT |
10.14 | 0.00 | 0.00 | 10.44 | |
Capex to Sales |
0.02 | 0.02 | 0.03 | 0.01 | |
Net Profit Margin |
1.67% | (3.79%) | 2.39% | 83.85% | |
Price to Operating Income |
12.80 | 0.00 | 0.00 | 13.57 | |
| Other line items | |||||
Average Receivables |
57.24 | 53.62 | 58.04 | 50.87 | |
Average Payables |
8.92 | 8.84 | 8.57 | 9.68 | |
Average Inventory |
23.80 | 23.10 | 24.67 | 17.45 | |
Average Assets |
454.65 | 452.14 | 450.35 | 488.62 | |
Average Common Equity |
292.19 | 340.77 | 346.44 | 376.48 |
Columns are period end dates